Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3403512

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1nc(N(C)c2ccc3c(c2)OCO3)c2cc(C)oc2n1
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL3403512
Phase Preclinical
Structure Type MOL
InChI Key MLNZPKUVAATQRY-UHFFFAOYSA-N
6
Targets
8
Activities
1
Assay Types
0
PK Parameters
9
Publications
0
Known Names

Molecular Properties

297.3
MW (Da)
3.34
ALogP
6
HBA
0
HBD
60.6
PSA (Ų)
0.72
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C16H15N3O3
MW 297.31
Aromatic Rings 3
Heavy Atoms 22
NP-Likeness -0.69

Activity Summary

IC50 8 meas. best 7.7

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Vascular endothelial growth factor receptor 2
CHEMBL279
 IC50 7.7 7.7 19.9 2
A-431
CHEMBL614069
 IC50 7.31 7.31 48.9 1
Platelet-derived growth factor receptor beta
CHEMBL1913
 IC50 7.3 7.3 50.1 1
Platelet-derived growth factor receptor alpha
CHEMBL2007
 IC50 7.3 7.3 50.1 1
Epidermal growth factor receptor
CHEMBL203
 IC50 6.53 6.53 298.0 2
NON-PROTEIN TARGET
CHEMBL3879801
 IC50 4.42 4.42 38200.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Vascular endothelial growth factor receptor 2 IC50 = 19.9 nM 7.7 Inhibition of VEGFR2 in human U251 cells compound pretreated for 60 min before V... 25882519
Vascular endothelial growth factor receptor 2 IC50 = 19.9 nM 7.7 RTK inhibitory activity: RTK inhibitory activity of the compounds 2-12 were eval... -
A-431 IC50 = 48.9 nM 7.31 Antiproliferative activity against human A431 cells after 48 hrs by sulforhodami... 25882519
Platelet-derived growth factor receptor beta IC50 = 50.1 nM 7.3 Inhibition of PDGFR-beta in human U251 cells compound pretreated for 60 min befo... 25882519
Platelet-derived growth factor receptor alpha IC50 = 50.1 nM 7.3 RTK inhibitory activity: RTK inhibitory activity of the compounds 2-12 were eval... -
Epidermal growth factor receptor IC50 = 298.2 nM 6.53 Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF... 25882519
Epidermal growth factor receptor IC50 = 298.0 nM 6.53 RTK inhibitory activity: RTK inhibitory activity of the compounds 2-12 were eval... -
NON-PROTEIN TARGET IC50 = 38200.0 nM 4.42 Antiangiogenic activity in VEGF-165 and bFGF-stimulated chicken embryo chorioall... 25882519

Literature References

PubMed DOI Target Context # Activities
25882519 10.1016/j.bmc.2015.03.061 NON-PROTEIN TARGET 3
25882519 10.1016/j.bmc.2015.03.061 HeLa 3
25882519 10.1016/j.bmc.2015.03.061 Unchecked 2
25882519 10.1016/j.bmc.2015.03.061 SK-OV-3 1
25882519 10.1016/j.bmc.2015.03.061 MDA-MB-435 1
25882519 10.1016/j.bmc.2015.03.061 A-431 1
25882519 10.1016/j.bmc.2015.03.061 Platelet-derived growth factor receptor beta 1
25882519 10.1016/j.bmc.2015.03.061 Vascular endothelial growth factor receptor 2 1
25882519 10.1016/j.bmc.2015.03.061 Epidermal growth factor receptor 1

Data from ChEMBL 36 via Core Engine